The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of first-line prolgolimab and nurulimab versus nivolumab and ipilimumab in advanced or metastatic melanoma: Indirect treatment comparison.
 
Alexander Fedenko
No Relationships to Disclose
 
Maria Sedova
No Relationships to Disclose
 
Maxim Batov
No Relationships to Disclose
 
Alina Kolomeytseva
No Relationships to Disclose
 
Kirill Sapozhnikov
No Relationships to Disclose
 
Natalia Sableva
No Relationships to Disclose
 
Andrey Lazarev
No Relationships to Disclose
 
Daria Tolkacheva
No Relationships to Disclose
 
Andrey Kaprin
No Relationships to Disclose